Schwartz P.J., Breithardt G., Howard A.J., Julian D.G., and Rehnqvist Ahlberg N. Task Force Report: the legal implications of medical guidelines -a Task Force of the European Society of Cardiology. Eur Heart J 20 (1999) 1152-1157
Almanaseer Y., Mukherjee D., Kline-Rogers E.M., Kesterson S.K., Sonnad S.S., Rogers B., et al. Implementation of the ACC/AHA guidelines for preoperative cardiac risk assessment in a general medicine preoperative clinic: improving efficiency and preserving outcomes. Cardiology 103 (2005) 24-29
Poldermans D., Hoeks S.E., and Feringa H.H. Pre-operative risk assessment and risk reduction before surgery. J Am Coll Cardiol 51 (2008) 1913-1924
Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
Boersma E., Kertai M.D., Schouten O., Bax J.J., Noordzij P., Steyerberg E.W., et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118 (2005) 1134-1141
Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
Poldermans D., Bax J.J., Schouten O., Neskovic A.N., Paelinck B., Rocci G., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
Poldermans D., Boersma E., Bax J.J., Thomson I.R., Van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 (1999) 1789-1794
Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J.C., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
Naughton C., and Feneck R.O. The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery. Int J Clin Pract 61 (2007) 768-776
Mangano D.T. Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth 18 (2004) 1-6
Ferguson Jr. T.B., Hammill B.G., Peterson E.D., DeLong E.R., and Grover F.L. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73 (2002) 480-489
Carroll K., Majeed A., Firth C., and Gray J. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register. J Public Health Med 25 (2003) 29-35
National Center for Health Statistics. Health, Unites States; 2007.
Hoeks S.E., Scholte op Reimer W.J., Lenzen M.J., Van Urk H., Jorning P.J., Boersma E., et al. Guidelines for cardiac management in noncardiac surgery are poorly implemented in clinical practice: results from a peripheral vascular survey in the Netherlands. Anesthesiology 107 (2007) 537-544
Hoeks S.E., Scholte Op Reimer W.J., Schouten O., Lenzen M.J., Van Urk H., and Poldermans D. Statin use in the elderly: results from a peripheral vascular survey in The Netherlands. J Vasc Surg 48 (2008) 891-895
Hoeks S.E., Scholte op Reimer W.J.M., Van Gestel Y.R.B.M., Schouten O., Lenzen M.J., Flu W.-J., et al. Medication underuse during long-term follow-up in patients with peripheral arterial disease. Circ Cardiovasc Qual Outcomes (2009) CIRCOUTCOMES.109.868505
Wirthlin D.J., and Cambria R.P. Surgery-specific considerations in the cardiac patient undergoing noncardiac surgery. Prog Cardiovasc Dis 40 (1998) 453-468
Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E., Fleischmann K.E., Freeman W.K., et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116 (2007) 1971-1996
Schouten O., Dunkelgrun M., Feringa H.H., Kok N.F., Vidakovic R., Bax J.J., et al. Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 33 (2007) 544-549
Blankensteijn J.D., De Jong S.E., Prinssen M., Van der Ham A.C., Buth J., Van Sterkenburg S.M., et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 352 (2005) 2398-2405
Holte K., and Kehlet H. Postoperative ileus: a preventable event. Br J Surg 87 (2000) 1480-1493
Nguyen N.T., and Wolfe B.M. The physiologic effects of pneumoperitoneum in the morbidly obese. Ann Surg 241 (2005) 219-226
Gurusamy K.S., Samraj K., and Davidson B.R. Abdominal lift for laparoscopic cholecystectomy. Cochrane Database Syst Rev 2 (2008) CD006574
Hlatky M.A., Boineau R.E., Higginbotham M.B., Lee K.L., Mark D.B., Califf R.M., et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 64 (1989) 651-654
Fletcher G.F., Balady G.J., Amsterdam E.A., Chaitman B., Eckel R., Fleg J., et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104 (2001) 1694-1740
Biccard B.M. Relationship between the inability to climb two flights of stairs and outcome after major non-cardiac surgery: implications for the pre-operative assessment of functional capacity. Anaesthesia 60 (2005) 588-593
Wiklund R.A., Stein H.D., and Rosenbaum S.H. Activities of daily living and cardiovascular complications following elective, noncardiac surgery. Yale J Biol Med 74 (2001) 75-87
Morris C.K., Ueshima K., Kawaguchi T., Hideg A., and Froelicher V.F. The prognostic value of exercise capacity: a review of the literature. Am Heart J 122 (1991) 1423-1431
Detsky A.S., Abrams H.B., Forbath N., Scott J.G., and Hilliard J.R. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 146 (1986) 2131-2134
Goldman L., Caldera D.L., Nussbaum S.R., Southwick F.S., Krogstad D., Murray B., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297 (1977) 845-850
Maisel A.S., Bhalla V., and Braunwald E. Cardiac biomarkers: a contemporary status report. Nat Clin Pract Cardiovasc Med 3 (2006) 24-34
Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
Sabatine M.S., Morrow D.A., Giugliano R.P., Murphy S.A., Demopoulos L.A., DiBattiste P.M., et al. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation 109 (2004) 874-880
Cannon C.P., McCabe C.H., Wilcox R.G., Langer A., Caspi A., Berink P., et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 102 (2000) 149-156
Tsimikas S., Willerson J.T., and Ridker P.M. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47 Suppl 8 (2006) C19-C31
Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
Omland T., Sabatine M.S., Jablonski K.A., Rice M.M., Hsia J., Wergeland R., et al. Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 50 (2007) 205-214
Bibbins-Domingo K., Gupta R., Na B., Wu A.H.B., Schiller N.B., and Whooley M.A. N-Terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 297 (2007) 169-176
Feringa H.H.H., Bax J.J., Elhendy A., De Jonge R., Lindemans J., Schouten O., et al. Association of plasma Nterminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 98 (2006) 111-115
Dernellis J., and Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 92 (2006) 1645-1650
Rodseth R.N., Padayachee L., and Biccard B.M. A meta-analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 63 (2008) 1226-1233
Cuthbertson B.H., Card G., Croal B.L., McNeilly J., and Hillis G.S. The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery. Anaesthesia 62 (2007) 875-881
Cuthbertson B.H., Amiri A.R., Croal B.L., Rajagopalan S., Alozairi O., Brittenden J., et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 99 (2007) 170-176
Fox K., Garcia M.A., Ardissino D., Buszman P., Camici P.G., Crea F., et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27 (2006) 1341-1381
Jeger R.V., Probst C., Arsenic R., Lippuner T., Pfisterer M.E., Seeberger M.D., et al. Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J 151 (2006) 508-513
Noordzij P.G., Boersma E., Bax J.J., Feringa H.H., Schreiner F., Schouten O., et al. Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery. Am J Cardiol 97 (2006) 1103-1106
Klocke F.J., Baird M.G., Lorell B.H., Bateman T.M., Messer J.V., Berman D.S., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 42 (2003) 1318-1333
Kertai M.D., Boersma E., Bax J.J., Heijenbrok-Kal M.H., Hunink M.G., L'Talien G.J., et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 89 (2003) 1327-1334
Etchells E., Meade M., Tomlinson G., and Cook D. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a metaanalysis. J Vasc Surg 36 (2002) 534-540
Shaw L.J., Eagle K.A., Gersh B.J., and Douglas Miller D. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 27 (1996) 787-798
Elhendy A., Valkema R., Van Domburg R.T., Bax J.J., Nierop P.R., Cornel J.H., et al. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 39 (1998) 1662-1666
Sicari R., Nihoyannopoulos P., Evangelista A., Kasprzak J., Lancellotti P., Poldermans D., et al. Stress Echocardiography Expert Consensus Statement-Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 30 (2009) 278-289
Das M.K., Pellikka P.A., Mahoney D.W., Roger V.L., Oh J.K., McCully R.B., et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 35 (2000) 1647-1653
Nandalur K.R., Dwamena B.A., Choudhri A.F., Nandalur M.R., and Carlos R.C. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 50 (2007) 1343-1353
Rerkpattanapipat P., Morgan T.M., Neagle C.M., Link K.M., Hamilton C.A., and Hundley W.G. Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol 90 (2002) 416-419
Danias P.G., Roussakis A., and Ioannidis J.P. Diagnostic performance of coronary magnetic resonance angiography as compared against conventional X-ray angiography: a meta-analysis. J Am Coll Cardiol 44 (2004) 1867-1876
Hamon M., Biondi-Zoccai G.G., Malagutti P., Agostoni P., Morello R., Valgimigli M., et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J Am Coll Cardiol 48 (2006) 1896-1910
Gerber T.C., Carr J.J., Arai A.E., Dixon R.L., Ferrari V.A., Gomes A.S., et al. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation 119 (2009) 1056-1065
Pouleur A.C., Le Polain de Waroux J.B., Kefer J., Pasquet A., Coche E., Vanoverschelde J.L., et al. Usefulness of 40-slice multidetector row computed tomography to detect coronary disease in patients prior to cardiac valve surgery. Eur Radiol 17 (2007) 3199-3207
Boersma E., Poldermans D., Bax J.J., Steyerberg E.W., Thomson I.R., Banga J.D., et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285 (2001) 1865-1873
ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 167 (2003) 211-277
Reilly C.S. Can we accurately assess an individual's perioperative risk?. Br J Anaesth 101 (2008) 747-749
Brunelli A., Belardinelli R., Refai M., Salati M., Socci L., Pompili C., et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest 135 (2009) 1260-1267
Older P., Smith R., Courtney P., and Hone R. Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest 104 (1993) 701-704
Piepoli M.F., Corra U., Agostoni P.G., Belardinelli R., Cohen-Solal A., Hambrecht R., et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Recommendations for performance and interpretation. Eur J Cardiovasc Prev Rehabil 13 (2006) 10-12
Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernandez-Aviles F., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28 (2007) 1598-1660
Silber S., Albertsson P., Aviles F.F., Camici P.G., Colombo A., Hamm C., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
Van de Werf F., Bax J., Betriu A., Blomstrom-Lundqvist C., Crea F., Falk V., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 29 (2008) 2909-2945
Cruickshank J.M. Are we misunderstanding beta-blockers. Int J Cardiol 120 (2007) 10-27
Raby K.E., Brull S.J., Timimi F., Akhtar S., Rosenbaum S., Naimi C., et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88 (1999) 477-482
Brady A.R., Gibbs J.S., Greenhalgh R.M., Powell J.T., and Sydes M.R. Perioperative betablockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
Juul A.B., Wetterslev J., Gluud C., Kofoed-Enevoldsen A., Jensen G., Callesen T., et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332 (2006) 1482
Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 (1996) 1713-1720
Yang H., Raymer K., Butler R., Parlow J., and Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152 (2006) 983-990
Zaugg M., Bestmann L., Wacker J., Lucchinetti E., Boltres A., Schulz C., et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107 (2007) 33-44
Auerbach A.D., and Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 287 (2002) 1435-1444
McGory M.L., Maggard M.A., and Ko C.Y. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?. Surgery 138 (2005) 171-179
Schouten O., Shaw L.J., Boersma E., Bax J.J., Kertai M.D., Feringa H.H., et al. A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coron Artery Dis 17 (2006) 173-179
Stevens R.D., Burri H., and Tramer M.R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 97 (2003) 623-633
Bangalore S., Wetterslev J., Pranesh S., Sahney S., Gluud C., and Messerli F.H. Perioperative b blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 372 (2008) 1962-1976
Devereaux P.J., Beattie W.S., Choi P.T., Badner N.H., Guyatt G.H., Villar J.C., et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 331 (2005) 313-321
Wiesbauer F., Schlager O., Domanovits H., Wildner B., Maurer G., Muellner M., et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg 104 (2007) 27-41
Beattie W.S., Wijeysundera D.N., Karkouti K., McCluskey S., and Tait G. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 106 (2008) 1039-1048
Lindenauer P.K., Pekow P., Wang K., Mamidi D.K., Gutierrez B., and Benjamin E.M. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
Dunkelgrun M., Boersma E., Schouten O., Koopman-Van Gemert A.W.M.M., Van Poorten F., Bax J.J., et al. Bisoprolol and fluvastin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing non-cardiovascular surgery; a randomized controlled trial (DECREASE-IV). Ann Surg 249 (2009) 921-926
Hoeks S.E., Scholte Op Reimer W.J., Van Urk H., Jorning P.J., Boersma E., Simoons M.L., et al. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vasc Endovasc Surg 33 (2007) 13-19
Shammash J.B., Trost J.C., Gold J.M., Berlin J.A., Golden M.A., and Kimmel S.E. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 41 (2001) 148-153
Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29 (2008) 2388-2442
Paravastu S.C., Mendonca D., and Da Silva A. Beta blockers for peripheral arterial disease. Cochrane Database Syst Rev 4 (2008) CD005508
Van Gestel Y.R.B.M., Hoeks S.E., Sin D.D., Welten G.M.J.M., Schouten O., Witteveen H.J., et al. Impact of cardioselective b-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 178 (2008) 695-700
Feringa H.H.H., Bax J.J., Boersma E., Kertai M.D., Meij S.H., Galal W., et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114 Suppl 1 (2006) I-344-9
Boersma E., and Poldermans D. Beta blockers in non-cardiac surgery: haemodynamic data needed. Lancet 372 (2008) 1930-1932
Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28 (2007) 2375-2414
Rosenson R.S., and Tangney C.C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 279 (1998) 1643-1650
Hindler K., Shaw A.D., Samuels J., Fulton S., Collard C.D., and Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105 (2006) 1260-1272
Williams T.M., and Harken A.H. Statins for surgical patients. Ann Surg 247 (2008) 30-37
Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leao P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-975
Schouten O., Boersma E., Hoeks S., Benner R., Van Urk H., Van Sambeek M.R.H.M., et al. Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery. Results from a randomized placebo controlled trial: DECREASE III. Eur Heart J 29 Suppl (2008)
Schouten O., Kertai M.D., Bax J.J., Durazzo A.E., Biagini E., Boersma E., et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 95 (2005) 658-660
Schouten O., Hoeks S.E., Welten G.M., Davignon J., Kastelein J.J., Vidakovic R., et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 100 (2007) 316-320
Coriat P., Daloz M., Bousseau D., Fusciardi J., Echter E., and Viars P. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous nitroglycerin. Anesthesiology 61 (1984) 193-196
Dodds T.M., Stone J.G., Coromilas J., Weinberger M., and Levy D.G. Prophylactic nitroglycerin infusion during noncardiac surgery does not reduce perioperative ischemia. Anesth Analg 76 (1993) 705-713
Sun Y.P., Zhu B.Q., Browne A.E., Pulukurthy S., Chou T.M., Sudhir K., et al. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. J Cardiovasc Pharmacol Ther 6 (2001) 175-181
Oosterga M., Voors A.A., Pinto Y.M., Buikema H., Grandjean J.G., Kingma J.H., et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 87 (2001) 542-546
Filion K.B., Pilote L., Rahme E., and Eisenberg M.J. Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: a systematic review. Am Heart J 154 (2007) 407-414
Wijeysundera D.N., and Beattie W.S. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 97 (2003) 634-641
Kertai M.D., Westerhout C.M., Varga K.S., Acsady G., and Gal J. Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery. Br J Anaesth 101 (2008) 458-465
Shchukin Iu V., Vachev A.N., Surkova E.A., Germanov A.V., Golovin E.A., and D'Iachkov V.A. The role of beta-adrenoblockers and If-inhibitor ivabradine in lowering of rate of development of cardiac complications after carotid endarterectomy. Kardiologiia 48 (2008) 56-59
Oliver M.F., Goldman L., Julian D.G., and Holme I. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 91 (1999) 951-961
Wallace A.W., Galindez D., Salahieh A., Layug E.L., Lazo E.A., Haratonik K.A., et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 101 (2004) 284-293
Wijeysundera D.N., Naik J.S., and Beattie W.S. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 114 (2003) 742-752
Vitez T.S., Soper L.E., Wong K.C., and Soper P. Chronic hypokalemia and intraoperative dysrhythmias. Anesthesiology 63 (1985) 130-133
Macdonald J.E., and Struthers A.D. What is the optimal serum potassium level in cardiovascular patients?. J Am Coll Cardiol 43 (2004) 155-161
Shah K.B., Kleinman B.S., Rao T.L., Jacobs H.K., Mestan K., and Schaafsma M. Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 70 (1990) 240-247
Domanski M., Norman J., Pitt B., Haigney M., Hanlon S., and Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 42 (2003) 705-708
Lindblad B., Persson N.H., Takolander R., and Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebocontrolled randomized trial. Stroke 24 (1993) 1125-1128
Robless P., Mikhailidis D.P., and Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 88 (2001) 787-800
Burger W., Chemnitius J.M., Kneissl G.D., and Rucker G. Low-dose aspirin for secondary cardiovascular prevention- cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 257 (2005) 399-414
Biondi-Zoccai G.G., Lotrionte M., Agostoni P., Abbate A., Fusaro M., Burzotta F., et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27 (2006) 2667-2674
Douketis J.D., Johnson J.A., and Turpie A.G. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 164 (2004) 1319-1326
Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 (2007) 230-268
De Caterina R., Husted S., Wallentin L., Agnelli G., Bachmann F., Baigent C., et al. Anticoagulants in heart disease: current status and perspectives. Eur Heart J 28 (2007) 880-913
Pengo V., Cucchini U., Denas G., Erba N., Guazzaloca G., La Rosa L., et al., For the Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic T. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery. an inception cohort management study. Circulation 119 (2009) 2920-2927
Poldermans D., Boersma E., Bax J.J., Kliffen M., Van Urk H., Van de Ven L., et al. Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol 88 (2001) 1413-1414
Eagle K.A., Rihal C.S., Mickel M.C., Holmes D.R., Foster E.D., and Gersh B.J. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 96 (1997) 1882-1887
Huber K.C., Evans M.A., Bresnahan J.F., Gibbons R.J., and Holmes Jr. D.R. Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clin Proc 67 (1992) 15-21
Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1294
Howard-Alpe G.M., De Bono J., Hudsmith L., Orr W.P., Foex P., and Sear J.W. Coronary artery stents and non-cardiac surgery. Br J Anaesth 98 (2007) 560-574
Nuttall G.A., Brown M.J., Stombaugh J.W., Michon P.B., Hathaway M.F., Lindeen K.C., et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 109 (2008) 588-595
Rabbitts J.A., Nuttall G.A., Brown M.J., Hanson A.C., Oliver W.C., Holmes D.R., et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 109 (2008) 596-604
Douketis J.D., Berger P.B., Dunn A.S., Jaffer A.K., Spyropoulos A.C., Becker R.C., et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 Suppl 6 (2008) S299-S339
McFalls E.O., Ward H.B., Moritz T.E., Goldman S., Krupski W.C., Littooy F., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
Poldermans D., Schouten O., Vidakovic R., Bax J.J., Thomson I.R., Hoeks S.E., et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 49 (2007) 1763-1769
Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
Kazmers A., Cerqueira M.D., and Zierler R.E. Perioperative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg 8 (1988) 307-315
Hammill B.G., Curtis L.H., Bennett-Guerrero E., O'Connor C.M., Jollis J.G., Schulman K.A., et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 108 (2008) 559-567
Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
Karagiannis S.E., Feringa H.H., Vidakovic R., Van Domburg R., Schouten O., Bax J.J., et al. Value of myocardial viability estimation using dobutamine stress echocardiography in assessing risk preoperatively before noncardiac vascular surgery in patients with left ventricular ejection fraction <35%. Am J Cardiol 99 (2007) 1555-1559
Feringa H.H., Bax J.J., Schouten O., and Poldermans D. Protecting the
Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. The Task Force for the management of arterial hypertension of the European Society of Hypertension, the Task Force for the management of arterial hypertension of the European Society of C. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28 (2007) 1462-1536
Weksler N., Klein M., Szendro G., Rozentsveig V., Schily M., Brill S., et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery?. J Clin Anesth 15 (2003) 179-183
Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Barwolf C., Levang O.W., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003) 1231-1243
Kertai M.D., Bountioukos M., Boersma E., Bax J.J., Thomson I.R., Sozzi F., et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 116 (2004) 8-13
Vahanian A., Alfieri O., Al-Attar N., Antunes M., Bax J., Cormier B., et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 29 (2008) 1463-1470
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). Eur Heart J; doi:10.1093/eurheartj/ehp285.
Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 (2007) 1736-1754
Forrest J.B., Cahalan M.K., Rehder K., Goldsmith C.H., Levy W.J., Strunin L., et al. Multicenter study of general anesthesia. II. Results. Anesthesiology 72 (1990) 262-268
Forrest J.B., Rehder K., Cahalan M.K., and Goldsmith C.H. Multicenter study of general anesthesia. III. Predictors of severe perioperative adverse outcomes. Anesthesiology 76 (1992) 3-15
Katz R.L., and Bigger Jr. J.T. Cardiac arrhythmias during anesthesia and operation. Anesthesiology 33 (1970) 193-213
Bertrand C.A., Steiner N.V., Jameson A.G., and Lopez M. Disturbances of cardiac rhythm during anesthesia and surgery. JAMA 216 (1971) 1615-1617
Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) e247-e346
Amar D. Perioperative atrial tachyarrhythmias. Anesthesiology 97 (2002) 1618-1623
Cox J.L. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 56 (1993) 405-409
O'Kelly B., Browner W.S., Massie B., Tubau J., Ngo L., and Mangano D.T. Ventricular arrhythmias in patients undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 268 (1992) 217-221
Polanczyk C.A., Goldman L., Marcantonio E.R., Orav E.J., and Lee T.H. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med 129 (1998) 279-285
Amar D., Zhang H., Miodownik S., and Kadish A.H. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol 42 (2003) 1262-1268
Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27 (2006) 1979-2030
Maisel W.H., Rawn J.D., and Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001) 1061-1073
Balser J.R., Martinez E.A., Winters B.D., Perdue P.W., Clarke A.W., Huang W., et al. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 89 (1998) 1052-1059
Bayliff C.D., Massel D.R., Inculet R.I., Malthaner R.A., Quinton S.D., Powell F.S., et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 67 (1999) 182-186
Jakobsen C.J., Bille S., Ahlburg P., Rybro L., Hjortholm K., and Andresen E.B. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 11 (1997) 746-751
Mahla E., Rotman B., Rehak P., Atlee J.L., Gombotz H., Berger J., et al. Perioperative ventricular dysrhythmias in patients with structural heart disease undergoing noncardiac surgery. Anesth Analg 86 (1998) 16-21
Vardas P.E., Auricchio A., Blanc J.J., Daubert J.C., Drexler H., Ector H., et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28 (2007) 2256-2295
Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39 (2002) 542-553
Gregoratos G., Cheitlin M.D., Conill A., Epstein A.E., Fellows C., Ferguson Jr. T.B., et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 31 (1998) 1175-1209
Erdman S., Levinsky L., Servadio C., Stoupel E., and Levy M.J. Safety precautions in the management of patients with pacemakers when electrocautery operations are performed. Surg Gynecol Obstet 167 (1988) 311-314
Potyk D., and Raudaskoski P. Preoperative cardiac evaluation for elective noncardiac surgery. Arch Fam Med 7 (1998) 164-173
Simon A.B. Perioperative management of the pacemaker patient. Anesthesiology 46 (1977) 127-131
Madigan J.D., Choudhri A.F., Chen J., Spotnitz H.M., Oz M.C., and Edwards N. Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg 230 (1999) 639-647
Pinski S.L., and Trohman R.G. Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist. Ann Intern Med 122 (1995) 770-777
Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
Kertai M.D., Boersma E., Bax J.J., Van den Meiracker A.H., Van Urk H., Roelandt J.R., et al. Comparison between serum creatinine and creatinine clearance for the prediction of postoperative mortality in patients undergoing major vascular surgery. Clin Nephrol 59 (2003) 17-23
Welten G.M., Schouten O., Chonchol M., Hoeks S.E., Feringa H.H., Bax J.J., et al. Temporary worsening of renal function after aortic surgery is associated with higher longterm mortality. Am J Kidney Dis 50 (2007) 219-228
Kheterpal S., Tremper K.K., Englesbe M.J., O'Reilly M., Shanks A.M., Fetterman D.M., et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 107 (2007) 892-902
McCullough P.A., and Soman S.S. Contrast-induced nephropathy. Crit Care Clin 21 (2005) 261-280
Merten G.J., Burgess W.P., Gray L.V., Holleman J.H., Roush T.S., Kowalchuk G.J., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
Maioli M., Toso A., Leoncini M., Gallopin M., Tedeschi D., Micheletti C., et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52 (2008) 599-604
Salem D.N., Stein P.D., Al-Ahmad A., Bussey H.I., Horstkotte D., Miller N., et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 Suppl 3 (2004) S457-S482
Newman S., Stygall J., Hirani S., Shaefi S., and Maze M. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology 106 (2007) 572-590
Selim M. Perioperative stroke. N Engl J Med 356 (2007) 706-713
Armstrong M.J., Schneck M.J., and Biller J. Discontinuation of perioperative antiplatelet and anticoagulant therapy in stroke patients. Neurol Clin 24 (2006) 607-630
Sin D.D.W.L., and Man S.F. The relationship between reduced lung function and cardiovascular mortality. A population based study and a systview of the literature. Chest 127 (2005) 1952-1959
Ramakrishna G.S.J., Ravi B.S., Chandrasekaran K., and McGoon M.D. Impact of pulmonary hypertension on the outcomes of non cardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 45 (2005) 1691-1699
Welten G.M., Schouten O., Van Domburg R.T., Feringa H.H., Hoeks S.E., Dunkelgrun M., et al. The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg 34 (2007) 632-638
Van Gestel Y.R., Hoeks S.E., Sin D.D., Simsek C., Welten G.M., Schouten O., et al. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol 102 (2008) 192-196
Galie N, Hoeper NM, Humbert M, Torbicki A, Vachiery J-C, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009; in press, doi:10.1093/eurheartj/ehp297.
Biagini A., L'Abbate A., Testa R., Carpeggiani C., Mazzei M.G., Michelassi C., et al. Unreliability of conventional visual electrocardiographic monitoring for detection of transient ST segment changes in a coronary care unit. Eur Heart J 5 (1984) 784-791
Leung J.M., O'Kelly B., Browner W.S., Tubau J., Hollenberg M., and Mangano D.T. Prognostic importance of postbypass regional wall-motion abnormalities in patients undergoing coronary artery bypass graft surgery. SPI Research Group. Anesthesiology 71 (1989) 16-25
Leung J.M., Voskanian A., Bellows W.H., and Pastor D. Automated electrocardiograph ST segment trending monitors: accuracy in detecting myocardial ischemia. Anesth Analg 87 (1998) 4-10
Kaplan J.A., and King III S.B. The precordial electrocardiographic lead (V5) in patients who have coronary-artery disease. Anesthesiology 45 (1976) 570-574
London M.J., Hollenberg M., Wong M.G., Levenson L., Tubau J.F., Browner W., et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology 69 (1988) 232-241
Landesberg G., Mosseri M., Wolf Y., Vesselov Y., and Weissman C. Perioperative myocardial ischemia and infarction: identification by continuous 12-lead electrocardiogram with online ST-segment monitoring. Anesthesiology 96 (2002) 264-270
Kertai M.D., Boersma E., Klein J., Van Urk H., Bax J.J., and Poldermans D. Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur J Vasc Endovasc Surg 28 (2004) 59-66
Landesberg G., Shatz V., Akopnik I., Wolf Y.G., Mayer M., Berlatzky Y., et al. Association of cardiac troponin, CKMB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 42 (2003) 1547-1554
Martinez E.A., Kim L.J., Faraday N., Rosenfeld B., Bass E.B., Perler B.A., et al. Sensitivity of routine intensive care unit surveillance for detecting myocardial ischemia. Crit Care Med 31 (2003) 2302-2308
Drew B.J., and Krucoff M.W. Multilead ST-segment monitoring in patients with acute coronary syndromes: a consensus statement for healthcare professionals. ST-Segment Monitoring Practice Guideline International Working Group. Am J Crit Care 8 (1999) 372-386
Landesberg G., Luria M.H., Cotev S., Eidelman L.A., Anner H., Mosseri M., et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 341 (1993) 715-719
Fleisher L.A. Real-time intraoperative monitoring of myocardial ischemia in noncardiac surgery. Anesthesiology 92 (2000) 1183-1188
Mangano D.T., Browner W.S., Hollenberg M., London M.J., Tubau J.F., and Tateo I.M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 323 (1990) 1781-1788
Mangano D.T., and Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 333 (1995) 1750-1756
London M.J., Tubau J.F., Wong M.G., Layug E., Hollenberg M., Krupski W.C., et al. The 'natural history' of segmental wall motion abnormalities in patients undergoing noncardiac surgery. S.P.I. Research Group. Anesthesiology 73 (1990) 644-655
Eisenberg M.J., London M.J., Leung J.M., Browner W.S., Hollenberg M., Tubau J.F., et al. Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Perioperative Ischemia Research Group. JAMA 268 (1992) 210-216
Practice guidelines for perioperative transesophageal echocardiography. A report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 84 (1996) 986-1006
Polanczyk C.A., Rohde L.E., Goldman L., Cook E.F., Thomas E.J., Marcantonio E.R., et al. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. JAMA 286 (2001) 309-314
Sandham J.D., Hull R.D., Brant R.F., Knox L., Pineo G.F., Doig C.J., et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348 (2003) 5-14
Feringa H.H., Vidakovic R., Karagiannis S.E., Dunkelgrun M., Elhendy A., Boersma E., et al. Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med 25 (2008) 314-319
Noordzij P.G., Boersma E., Schreiner F., Kertai M.D., Feringa H.H.H., Dunkelgrun M., et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 156 (2007) 137-142
International Diabetes Federation. Diabetes atlas. 2006.
Umpierrez G.E., Isaacs S.D., Bazargan N., You X., Thaler L.M., and Kitabchi A.E. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87 (2002) 978-982
Vanhorebeek I., Langouche L., and Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 132 (2007) 268-278
Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
Gandhi G.Y., Nuttall G.A., Abel M.D., Mullany C.J., Schaff H.V., O'Brien P.C., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 146 (2007) 233-243
Ammori J.B., Sigakis M., Englesbe M.J., O'Reilly M., and Pelletier S.J. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res 140 (2007) 227-233
Ellger B., Debaveye Y., Vanhorebeek I., Langouche L., Giulietti A., Van Etten E., et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 (2006) 1096-1105
Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D., Dhingra V., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (2009) 1283-1297
De Hert S.G., Turani F., Mathur S., and Stowe D.F. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 100 (2005) 1584-1593
Slogoff S., and Keats A.S. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 70 (1989) 179-188
Rodgers A., Walker N., Schug S., McKee A., Kehlet H., Van Zundert A., et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 321 (2000) 1493
Wu C.L., Rowlingson A.J., Herbert R., Richman J.M., Andrews R.A., and Fleisher L.A. Correlation of postoperative epidural analgesia on morbidity and mortality after colectomy in Medicare patients. J Clin Anesth 18 (2006) 594-599
Bode Jr. R.H., Lewis K.P., Zarich S.W., Pierce E.T., Roberts M., Kowalchuk G.J., et al. Cardiac outcome after peripheral vascular surgery. Comparison of general and regional anesthesia. Anesthesiology 84 (1996) 3-13
Mauermann W.J., Shilling A.M., and Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 103 (2006) 1018-1025
Rigg J.R., Jamrozik K., Myles P.S., Silbert B.S., Peyton P.J., Parsons R.W., et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 359 (2002) 1276-1282
Birkmeyer J.D., Stukel T.A., Siewers A.E., Goodney P.P., Wennberg D.E., and Lucas F.L. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
Liu S.S., and Wu C.L. The effect of analgesic technique on postoperative patientreported outcomes including analgesia: a systematic review. Anesth Analg 105 (2007) 789-808
White P.F., and Kehlet H. Postoperative pain management and patient outcome: time to return to work?. Anesth Analg 104 (2007) 487-489
Polomano R.C., Rathmell J.P., Krenzischek D.A., and Dunwoody C.J. Emerging trends and new approaches to acute pain management. J Perianesth Nurs 23 Suppl 1 (2008) S43-S53
Dolin S.J., Cashman J.N., and Bland J.M. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth 89 (2002) 409-423
Jorgensen H., Wetterslev J., Moiniche S., and Dahl J.B. Epidural local anaesthetics versus opioid-based analgesic regimens on postoperative gastrointestinal paralysis, PONV and pain after abdominal surgery. Cochrane Database Syst Rev 4 (2000) CD001893
Block B.M., Liu S.S., Rowlingson A.J., Cowan A.R., Cowan Jr. J.A., and Wu C.L. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA 290 (2003) 2455-2463
Schug S.A., and Manopas A. Update on the role of non-opioids for postoperative pain treatment. Best Pract Res Clin Anaesthesiol 21 (2007) 15-30
